Is AEON (AEON) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 48.3% / 30% | 0.0% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 48.3% / 33% | 0.0% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 412.3% / 33% | 0.4% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 48.3% / 33% | 0.0% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 412.3% / 33% | 0.4% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -165.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$20M |
| Free Cash Flow | -$20M |
| Total Debt | $13M |
| Current Ratio | 0.9 |
| Total Assets | $3M |
Price & Trading
| Last Close | $1.00 |
| 50-Day MA | $1.12 |
| 200-Day MA | $0.93 |
| Avg Volume | 157K |
| Beta | 0.7 |
|
52-Week Range
$0.38
| |
About AEON (AEON)
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is AEON (AEON) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), AEON is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is AEON's debt ratio?
AEON's debt ratio is 48.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 412.3%.
What are AEON's key financial metrics?
AEON has a market capitalization of $29M, trailing P/E ratio of 0.4.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.